<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Prev Med</journal-id><journal-id journal-id-type="iso-abbrev">Int J Prev Med</journal-id><journal-id journal-id-type="publisher-id">IJPVM</journal-id><journal-title-group><journal-title>International Journal of Preventive Medicine</journal-title></journal-title-group><issn pub-type="ppub">2008-7802</issn><issn pub-type="epub">2008-8213</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25709792</article-id><article-id pub-id-type="pmc">4336987</article-id><article-id pub-id-type="publisher-id">IJPVM-5-1567</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effect of Conjugated Linoleic Acid, Vitamin E, Alone or Combined on Immunity and Inflammatory Parameters in Adults with Active Rheumatoid Arthritis: A Randomized Controlled Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Aryaeian</surname><given-names>Naheed</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Djalali</surname><given-names>Mahmoud</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Shahram</surname><given-names>Farhad</given-names></name><xref ref-type="aff" rid="aff3">2</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Djazayery</surname><given-names>Abolghassem</given-names></name><xref ref-type="aff" rid="aff4">3</xref></contrib><contrib contrib-type="author"><name><surname>Eshragian</surname><given-names>Mohammad Reza</given-names></name><xref ref-type="aff" rid="aff5">4</xref></contrib></contrib-group><aff id="aff1">Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran</aff><aff id="aff2"><label>1</label>Department of Cellular and Molecular Nutrition, School of Nutrition and Dietetics, Tehran University of Medical Sciences, Tehran, Iran</aff><aff id="aff3"><label>2</label>Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran</aff><aff id="aff4"><label>3</label>Department of Public Nutrition, School of Nutrition and Dietetics, Tehran University of Medical Sciences, Tehran, Iran</aff><aff id="aff5"><label>4</label>Department of Biostatistics and Epidemiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</aff><author-notes><corresp id="cor1"><bold>Correspondence to:</bold> Prof. Farhad Shahram, Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran. E-mail: <email xlink:href="shahramf@tums.ac.ir">shahramf@tums.ac.ir</email></corresp></author-notes><pub-date pub-type="ppub"><month>12</month><year>2014</year></pub-date><volume>5</volume><issue>12</issue><fpage>1567</fpage><lpage>1577</lpage><history><date date-type="received"><day>25</day><month>9</month><year>2013</year></date><date date-type="accepted"><day>21</day><month>10</month><year>2014</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; International Journal of Preventive Medicine</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>Little information about the effects of conjugated linoleic acids (CLAs) on inflammation and immune function in humans is available. This study investigated the effects of CLAs, with and without Vitamin E on immunity and inflammatory parameters in adults with active rheumatoid arthritis (RA).</p></sec><sec id="st2"><title>Methods:</title><p>In a double-blind clinical trial, 78 patients were randomly divided into four groups, each group receiving one of the following daily supplement for 3 months; group C: 2.5 g CLAs, group E: 400 mg Vitamin E, group CE: CLAs plus Vitamin E, group <italic>P</italic>: Placebo. Cytokines, matrix metalloproteinase 3 (MMP-3) and citrullinated antibody (CCP-A) were measured by ELISA method and Vitamin E by high-performance liquid chromatography.</p></sec><sec id="st3"><title>Results:</title><p>Consider statistical methods there were no significant differences between groups in cytokines interleukin-2 (IL-2), IL-4, tumor necrosis factor-&#x003b1; (TNF-&#x003b1;), IL-1&#x003b2;, IL-2/IL-4, CCP-A white blood cells and neutrophils, lymphocyte, monocytes, and eosinophils numbers. TNF-&#x003b1; decreased in all groups, but its reduction was significant in group CE. IL-1&#x003b2; increased in groups P (<italic>P</italic> = 0.004) and E (<italic>P</italic> = 0.041) but the difference between group P and CE was significant. IL-4 decreased in groups C, CE and E (<italic>P</italic> = 0.03, <italic>P</italic> = 0.03, <italic>P</italic> = 0.07 respectively). IL2 did not change significantly within groups. CCP-A increased in groups P (<italic>P</italic> = 0.035) and E (<italic>P</italic> = 0.05), while it decreased in groups CE (<italic>P</italic> = 0.034). CCP-A and MMP-3 decrease were significant between groups P and CE. MMP-3 reduction was significant in group CE.</p></sec><sec id="st4"><title>Conclusions:</title><p>Co-supplementation CLAs and Vitamin E may be effective in the level of inflammatory markers in RA patients.</p></sec></abstract><kwd-group><kwd>Conjugated linoleic acids</kwd><kwd>immunity</kwd><kwd>inflammatory markers</kwd><kwd>rheumatoid arthritis</kwd><kwd>Vitamin E</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Rheumatoid arthritis (RA) is a chronic relapsing inflammatory multisystem disease with synovial proliferation and destruction of articular cartilage. It is the most common inflammatory arthritis, affecting approximately 0.5-1% of the general population worldwide.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>] RA has served as a useful model for the study of many inflammatory and immune-mediated diseases.[<xref rid="ref1" ref-type="bibr">1</xref>] The exact cause of RA is not yet known. Recently, several studies have shown the possible role of reactive oxygen species (ROS) in the pathogenesis of RA.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref><xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref><xref rid="ref9" ref-type="bibr">9</xref>] The destructive reactions by ROS can be improved by antioxidants.[<xref rid="ref8" ref-type="bibr">8</xref>] Antioxidants have beneficial effect for inhibition of inflammation related to neutrophil functions,[<xref rid="ref9" ref-type="bibr">9</xref>] Vitamin E as a potent antioxidant has an ability to modulate host immune functions,[<xref rid="ref10" ref-type="bibr">10</xref>] so it may be have positive effect on patients who suffer from RA.[<xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref12" ref-type="bibr">12</xref><xref rid="ref13" ref-type="bibr">13</xref>]</p><p>Conjugated linoleic acids (CLAs) are naturally occurring isomers of linoleic acid found in meat and milk of grazing animals.[<xref rid="ref14" ref-type="bibr">14</xref>] Their anti-inflammatory effects that have been shown can protect bones from damage.[<xref rid="ref14" ref-type="bibr">14</xref><xref rid="ref15" ref-type="bibr">15</xref>] The biological activities of CLAs, much attention has been due to their anticancer,[<xref rid="ref16" ref-type="bibr">16</xref>] antiatherogenic[<xref rid="ref17" ref-type="bibr">17</xref><xref rid="ref18" ref-type="bibr">18</xref>] and antidiabetic effects,[<xref rid="ref19" ref-type="bibr">19</xref>] as well as their effect on increasing the bone mass.[<xref rid="ref20" ref-type="bibr">20</xref>] The role of CLAs in oxidative stress as an antioxidant has been investigated to explain its beneficial physiological effects.[<xref rid="ref21" ref-type="bibr">21</xref><xref rid="ref22" ref-type="bibr">22</xref><xref rid="ref23" ref-type="bibr">23</xref><xref rid="ref24" ref-type="bibr">24</xref><xref rid="ref25" ref-type="bibr">25</xref><xref rid="ref26" ref-type="bibr">26</xref><xref rid="ref27" ref-type="bibr">27</xref><xref rid="ref28" ref-type="bibr">28</xref>] In previous articles we reported the effects of CLAs on RA by a randomized, double-blind placebo-controlled trial. Pain and morning stiffness were significantly lower in the group taking CLA or CLA plus Vitamin E, compared to placebo the group after 12 weeks of supplementation. We have concluded that CLAs may improve clinical outcomes;[<xref rid="ref28" ref-type="bibr">28</xref>] lower lipid peroxidation[<xref rid="ref29" ref-type="bibr">29</xref>] without negative effects on lipid profile and fasting blood sugar in patients with RA.[<xref rid="ref30" ref-type="bibr">30</xref>]</p><p>Other studies suggest that the CLA can also inhibit the cyclooxygenase (COX-1) and COX-2 pathway enzymes that enhance inflammation in diseases such as RA.[<xref rid="ref31" ref-type="bibr">31</xref><xref rid="ref32" ref-type="bibr">32</xref><xref rid="ref33" ref-type="bibr">33</xref>] It is well established that lipids can influence both the inflammatory responses and T-cell functions.[<xref rid="ref34" ref-type="bibr">34</xref>] CLAs have been reported to have anti-inflammatory and immune-regulatory effects on healthy animals.[<xref rid="ref35" ref-type="bibr">35</xref><xref rid="ref36" ref-type="bibr">36</xref><xref rid="ref37" ref-type="bibr">37</xref>] In contrast to the animal studies, clinical trials in healthy persons have reported few effects of CLA on immune function.[<xref rid="ref34" ref-type="bibr">34</xref><xref rid="ref38" ref-type="bibr">38</xref><xref rid="ref39" ref-type="bibr">39</xref><xref rid="ref40" ref-type="bibr">40</xref><xref rid="ref41" ref-type="bibr">41</xref><xref rid="ref42" ref-type="bibr">42</xref><xref rid="ref43" ref-type="bibr">43</xref><xref rid="ref44" ref-type="bibr">44</xref>] There are controversial results about changing Plasma C-reactive protein values.[<xref rid="ref45" ref-type="bibr">45</xref><xref rid="ref46" ref-type="bibr">46</xref><xref rid="ref47" ref-type="bibr">47</xref><xref rid="ref48" ref-type="bibr">48</xref>] To our knowledge there has not been any study on CLAs and/or its combination with Vitamin E on immunity and inflammation in patients with RA. The objective of the study was to determine the effects of oral administration of c9t11 and t10c12 CLA, Vitamin E supplement alone and in combination with Vitamin E supplement, on immunological and inflammatory parameters in active RA.</p></sec><sec sec-type="methods" id="sec1-2"><title>METHODS</title><sec id="sec2-1"><title>Subjects</title><p>This study was a randomized, double-blind placebo-controlled trial that conducted in a 3 months period in patients with active RA. The inclusion criteria were ages between 18 and 69 years having RA for at least 2 years and fulfilling 1987 American College of Rheumatology criteria for RA.[<xref rid="ref49" ref-type="bibr">49</xref>]</p><p>The exclusion criteria were: Taking vitamin and fatty acids/or mineral supplements, thyroid hormones, estrogens, progesterone, diuretics or &#x003b2;-blockers, abnormal renal and hepatic function, history of myocardial infarction, diabetes, hyperlipidemia and for the females, not being pregnant.</p><p>The subjects were fully informed of the purpose, procedures, and hazards of the trial and had the right to leave the trial at any time. Written consent was obtained from all patients. The study has been approved by the Ethics Committee on Human Experimentation of the Tehran University of Medical Sciences.</p></sec><sec id="sec2-2"><title>Design</title><p>The patients were randomly allocated using Random Permuted Blocks procedure to one of following four treatment groups. All patients in either treatment groups received two capsules and one pearl daily for a period of 3 months as follow. For group C: Two CLA capsules (2 capsules 1.25 g/day that contained 80% CLA, equal 2 g 50:50 mix of cis - 9, trans - 11 and trans - 10, cis - 12 glycerinated CLA and one Vitamin E placebo pearl; group CE: Two CLA capsules and One Vitamin E pearl; group E: One Vitamin E (&#x003b1; tocopherol) pearl (400 mg/day) and two CLA placebo capsules; for group <italic>P</italic>: Two CLA placebo capsules and one placebo pearl. Placebo capsules contained corn oil (CO) in replacing of Vitamin E and high oleic sunflower oil in replace of CLA. Vitamin E and its placebo were specially prepared for this study by Zahravey Company, and CLA and its placebo by Lipid Nutrition Company.</p></sec><sec id="sec2-3"><title>Biochemical analysis</title><p>Blood sample collection: A sample of 15 ml blood was obtained from each patient before the trial and at the end of it. The patients were fast for 12&#x02013;14 h. Ethylene diamine tetra acetic acid as anticoagulant was used for plasma isolation.</p><p>Plasma &#x003b1;-tocopherol was measured by high-performance liquid chromatography (Cuesta&#x02013;Sanz method) with a C15 column and ultraviolet&#x02013;visible detector.[<xref rid="ref50" ref-type="bibr">50</xref>]</p><p>Measurement of plasma inflammatory and immunity reactants: Plasma cytokines were done by ELISA method[<xref rid="ref51" ref-type="bibr">51</xref><xref rid="ref52" ref-type="bibr">52</xref><xref rid="ref53" ref-type="bibr">53</xref><xref rid="ref54" ref-type="bibr">54</xref>] and by human high sensitivity ELISA kits from eBioscience Company [USA] (sensitivities for interleukin-2 (IL-2), IL-4, IL-1, tumor necrosis factor-&#x003b1; (TNF-&#x003b1;) were 0.4, 0.1, 0.05, 0.13 pg/ml, respectively). Matrix metalloproteinase 3 (MMP-3) was measured by human ELISA Platinum kits from Ebioscience Company; sensitivity was 0.008 ng/ml. Citrullinated antibody (CPP-A) was measured by ELISA method for IgG Antibody citrullinated protein and kits produced by Genesis (England) company, and clinical sensitivity was 80%.[<xref rid="ref55" ref-type="bibr">55</xref>]</p><p>Hematological values were determined by an automated blood counter (Beckman Coulter, Miami, USA).</p><p>Nutrients intakes were estimated using 24 h dietary recall questionnaire before and at the end of the trial for 3 days analyzed by Nutrition IV(San Bruno, CA, USA, Firsty Data Bank) software. The subjects were asked not to change their usual diets and physical activities throughout the study, and any changes in their medications were avoided if possible.</p><p>Compliance with the supplement intake was assessed by counting number of the capsules used and determining changes in the plasma &#x003b1;-tocopherol.</p></sec><sec id="sec2-4"><title>Statistics methods</title><p>Differences between the four groups were determined by ANOVA (one-way analysis of variance) for continuous data and the Chi-square test for group data. Log transformation was used to normalize the abnormal distributions. Differences between before and after data in each group were determined with paired-sample <italic>t</italic>-test. If the distribution of a variable was not normal, Mann&#x02013;Whitney U-test was used to compare the differences between two groups and Wilcoxon signed-rank test was performed for each group to compare mean values before and after intervention. ANOCVA were used to adjust the effect of confounding factors. Correlation was determined by Pearson test. <italic>P</italic> &#x0003c; 0.05 was considered as statistically significant. (Version 18; SPSS Inc., Chicago, Il, USA) was used for data analysis. Quantitative values are reported as mean &#x000b1; standard deviation.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>Totally 102 subjects entered to the study, and 87 of them completed the study. Fifteen patients were excluded from the study due to either incomplete consumption of prescribed drugs (6 patients: 1 in each groups C [CLA] and CE [CLA + Vitamin E], 2 in each groups E [Vitamin E] and P [Placebo]), changing the dose of their antiinflammatory drugs (8 patients: 2 in each groups), or side-effects (1 patient in group C).</p><p><xref ref-type="table" rid="T1">Table 1</xref> shows demographic, anthropometric data for the 4 study groups at the baseline. There were no significant differences among the four groups at the beginning of the study regarding age, sex, BMI, daily intake of vitamin E, disease duration and diseases activity score (<italic>P</italic> &#x0003e; 0.05). Also, the differences between drugs intake (NSAIDS, glucocorticoid and other disease-modifying antirheumatic drugs) weren&#x02019;t significant between groups (<italic>P</italic> &#x0003e; 0.05).[<xref rid="ref28" ref-type="bibr">28</xref>] The Plasma level of &#x003b1;-tocopherol increased significantly in groups E and CE in contrast to the placebo group (<italic>P</italic> &#x02264; 0.017, <italic>P</italic> &#x0003c; 0.023 respectively) [<xref ref-type="table" rid="T2">Table 2</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Demographic, anthropometric, and clinical data for the four study groups at the baseline (mean&#x000b1;SD)</p></caption><graphic xlink:href="IJPVM-5-1567-g001"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>The plasma levels of CCP-A, MMP-3, CRP and Vitamin E in patients with active RA before and after 3 months supplementation (mean&#x000b1;SD)</p></caption><graphic xlink:href="IJPVM-5-1567-g002"/></table-wrap><p>There were no significant differences between groups at the baseline in cytokines IL-2, IL-4, TNF-&#x003b1;, IL-1&#x003b2;, IL-2/IL-4 and citrullinated antibody variables [<xref ref-type="table" rid="T3">Tables 3</xref>] as well as white blood cell (WBC) [Tables <xref ref-type="table" rid="T2">2</xref> and <xref ref-type="table" rid="T4">4</xref>]. In this study, significant changes were not seen in neutrophils, lymphocyte, monocytes, eosinophils numbers and BMI after treatment between groups. Decrease in WBC count was significant in group CLA plus Vitamin E, and the lymphocytes increased in group P (<italic>P</italic> &#x02264; 0.05) [<xref ref-type="table" rid="T3">Table 3</xref>].</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Levels of some plasma cytokines in patients with active RA before and after 3 months supplementation (mean&#x000b1;SD)</p></caption><graphic xlink:href="IJPVM-5-1567-g003"/></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Levels of blood immunity cells in patients with active RA before and after 3 months supplementation (mean&#x000b1;SD)</p></caption><graphic xlink:href="IJPVM-5-1567-g004"/></table-wrap><p>Although TNF-&#x003b1; was reduced during the study in all groups, this reduction was significant only in group CE [<xref ref-type="table" rid="T3">Table 3</xref>] (<italic>P</italic> &#x0003c; 0.05). IL1&#x003b2; increased significantly in group P and E but decreased in group CE (<italic>P</italic> &#x0003e; 0.05). The increase in IL-1&#x003b2; in group E was lower than Placebo. The IL-4 decreased in groups C, E, CE (<italic>P</italic> = 0.03, <italic>P</italic> = 0.07 and <italic>P</italic> = 0.003 respectively), but didn&#x02019;t changed significantly in group P. No significant changes were seen in the plasma IL-2 levels in all groups, although increased in group P and decreased in other groups (<italic>P</italic> &#x0003e; 0.05). IL-2/IL-4 increased in all groups with <italic>P</italic> = 0.005, <italic>P</italic> = 0.016, <italic>P</italic> = 0.005, <italic>P</italic> = 0.006 for group P, CLAs, E and CE respectively, but differences between groups wasn&#x02019;t significant. CCP-A increased in group P and decreased in group CE significantly (<italic>P</italic> &#x02264; 0.05). The increase in CCP-A in group E was lower than Placebo. MMP-3 increased in group P and decreased in group CE (<italic>P</italic> &#x02264; 0.05), and the differences between group P and group CE was significant (<italic>P</italic> = 0.018) [<xref ref-type="table" rid="T3">Tables 3</xref>]. The difference between groups for all data except for CCP-A and MMP-3 wasn&#x02019;t significant.</p><p>No significant side effects were observed. There were three reports of flatulence (2 in group C and 1 in group CE). It was relieved in two patients by prescribing tablets during meals instead of before meals, but one patient in group C was needed to exclude.</p></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>Conjugated linoleic acids are groups of fatty acids with the geometrical and positional isomers of linoleic acid. CLAs were previously shown to reduce clinical signs of inflammatory diseases such as type I airway hypersensitivity,[<xref rid="ref56" ref-type="bibr">56</xref>] lupus,[<xref rid="ref57" ref-type="bibr">57</xref>] cancer,[<xref rid="ref58" ref-type="bibr">58</xref>] endotoxin-induced cachexia,[<xref rid="ref59" ref-type="bibr">59</xref>] inflammatory bowel disease,[<xref rid="ref60" ref-type="bibr">60</xref>] and renal failure.[<xref rid="ref61" ref-type="bibr">61</xref>] CLA reduces immune-induced TNF-&#x003b1;[<xref rid="ref62" ref-type="bibr">62</xref><xref rid="ref63" ref-type="bibr">63</xref>] and inducible COX2 expression, key mediators of inflammation in RA. It can also influence cell functions.[<xref rid="ref31" ref-type="bibr">31</xref><xref rid="ref63" ref-type="bibr">63</xref><xref rid="ref64" ref-type="bibr">64</xref><xref rid="ref65" ref-type="bibr">65</xref>] Based on previous work, it was hypothesized that dietary CLA would have anti-inflammatory effects on animal models of RA.[<xref rid="ref63" ref-type="bibr">63</xref><xref rid="ref64" ref-type="bibr">64</xref><xref rid="ref65" ref-type="bibr">65</xref><xref rid="ref66" ref-type="bibr">66</xref>] Some evidence suggests that CLA decreases antigen-induced cytokine production in immune competent cells, modulates the production of cytokines and leukotriene B4, has antioxidant effect,[<xref rid="ref63" ref-type="bibr">63</xref>] and is helpful for reducing symptoms and/or adverse effects of RA.[<xref rid="ref28" ref-type="bibr">28</xref>] CCP-A is a better index for prediction of erosive RA than ESR, CRP and MMP-3,[<xref rid="ref67" ref-type="bibr">67</xref>] and higher CCP-A concentrations are associated with increased disease activity in RA.[<xref rid="ref68" ref-type="bibr">68</xref>] In our study CCP-A significantly increased in group P (<italic>P</italic> = 0.035) and also E (<italic>P</italic> = 0.055) and decreased in group CE (<italic>P</italic> = 0.034). TNF-&#x003b1; was reduced during our study in treatment groups, but this reduction was significant only in group CE. IL-1&#x003b2; increased in group P (<italic>P</italic> = 0.004) and E (<italic>P</italic> = 0.041) and difference decrease was near significant between group CE, compared with group P (<italic>P</italic> = 0.061). Hence in group P increased CCP-A, MMP-3, and IL-1&#x003b2;, but in group E increased IL-1&#x003b2; and CCP-A (borderline significant, lower than placebo group) and in other groups we hadn&#x02019;t significant increase in those inflammatory parameters. There is evidence for the involvement of T-cells, especially CD<sup>4+</sup> T-cells, in the pathogenesis of RA and is thought to be a Th1 cell&#x02013;associated disorders rather than Th2[<xref rid="ref69" ref-type="bibr">69</xref>] therefore we measured IL-4 and IL-2 that respectively secreted by T helper-2 and helper-1 and their ratio. The IL4 decreased in groups C, CE and E (<italic>P</italic> = 0.03, <italic>P</italic> = 0.03 and <italic>P</italic> = 0.07 respectively), but did not change in group P significantly (<italic>P</italic> = 0.068). No significant changes were seen in the plasma levels of IL-2 in all groups [Table 5].</p><p>Song <italic>et al</italic>. studied the effect of dietary CLA supplementation (3 g/day) on the immune system in healthy humans. CLA supplementation also decreased the levels of the pro-inflammatory cytokines, TNF-&#x003b1; and IL-1&#x003b2; (<italic>P</italic> &#x0003c; 0.05) were similar to our findings, whereas the levels of the anti-inflammatory cytokine IL-10 increased (<italic>P</italic> &#x0003c; 0.05).[<xref rid="ref43" ref-type="bibr">43</xref>] In the Butz <italic>et al</italic>. study on the effect of CLA on collagen antibody-induced arthritis (CIA), CLA-fed mice had arthritic scores 70% that of the CO fed mice.[<xref rid="ref66" ref-type="bibr">66</xref>] Some previous studies on systemic lupus erythematos supported the effects of dietary CLAs. In one study CLA had a beneficial effect in the autoimmune NZB/W F1 mouse, because the cachectic symptom of systemic lupus erythematos was decreased by dietary CLA and survival days were increased over the control group.[<xref rid="ref59" ref-type="bibr">59</xref>] Several studies reported that CLA can reduce TNF-&#x003b1; levels and TNF-&#x003b1; related cachexia.[<xref rid="ref70" ref-type="bibr">70</xref><xref rid="ref71" ref-type="bibr">71</xref>]</p><p>Similar to our study, the mixed CLAS isomers reduce TNF-&#x003b1; level in animals and human primary muscle cells.[<xref rid="ref71" ref-type="bibr">71</xref><xref rid="ref72" ref-type="bibr">72</xref><xref rid="ref73" ref-type="bibr">73</xref>] CLAs have been shown to reduce pro-inflammatory cytokines, helping to decrease symptoms associated with inflammation.[<xref rid="ref33" ref-type="bibr">33</xref><xref rid="ref61" ref-type="bibr">61</xref><xref rid="ref62" ref-type="bibr">62</xref><xref rid="ref74" ref-type="bibr">74</xref>] However, there are reports that CLAs decreased IL-4 and increased IL-2 and interferon-&#x003b3; (IFN-&#x003b3;) in splenocytes and T-cells, with no effect on Plasma TNF-&#x003b1; levels or increased it in humans and rats,[<xref rid="ref41" ref-type="bibr">41</xref><xref rid="ref75" ref-type="bibr">75</xref>] which may reflect pro-inflammatory responses by CLAs.[<xref rid="ref47" ref-type="bibr">47</xref><xref rid="ref71" ref-type="bibr">71</xref>] The difference for the effects of CLAs on inflammatory responses may be due to the various isomer used, duration of treatment, tissue specificity and purity.[<xref rid="ref63" ref-type="bibr">63</xref><xref rid="ref76" ref-type="bibr">76</xref><xref rid="ref77" ref-type="bibr">77</xref>] However, the exact mechanism by which CLAs control cytokines are still not clear.[<xref rid="ref43" ref-type="bibr">43</xref>] CLAs may be exerting anti-inflammatory effect through peroxisome proliferator-activated receptors (PPARs). It has been reported that CLA's effects may be mediated through PPAR-&#x003b1; and PPAR-g.[<xref rid="ref62" ref-type="bibr">62</xref><xref rid="ref78" ref-type="bibr">78</xref>] Activation of PPAR-&#x003b3; inhibits production of inflammatory cytokines, such as TNF-&#x003b1;, IFN-&#x003b3;, IL-1 &#x003b2;, IL-6 and IL-8.[<xref rid="ref62" ref-type="bibr">62</xref><xref rid="ref77" ref-type="bibr">77</xref>] Some studies suggest that CLA may affect PPAR-&#x003b3; through nuclear factor-kB.[<xref rid="ref63" ref-type="bibr">63</xref><xref rid="ref77" ref-type="bibr">77</xref><xref rid="ref78" ref-type="bibr">78</xref><xref rid="ref79" ref-type="bibr">79</xref>]</p><p>CLAs are known to inhibit dendritic cell (DC) maturation and have antiinflammatory effects on DC following activation with lipopolysaccharide.[<xref rid="ref63" ref-type="bibr">63</xref>]</p><p>CLAs may have direct or indirect anti-inflammatory effect on the activity and expression of COX-2, thus decrease PGE2 production,[<xref rid="ref31" ref-type="bibr">31</xref><xref rid="ref80" ref-type="bibr">80</xref>] we saw a significant reduction in MMP-3 plasma levels in group CE. MMP-3 is an enzyme with abroad substrate specifies and causes joint proteoglycan and other matrix molecules degradation. The imbalance between MMP-3 and its inhibitors leads to joints destruction. MMP-3 increases in the synovial fluid of RA patients and especially in active RA disease and hence it may be a useful biomarker of response to treatment.[<xref rid="ref81" ref-type="bibr">81</xref>]</p><p>It has been suggested that nonenzymatic and enzymatic antioxidant systems are impaired in RA; so patients with RA are exposed to oxidant stress.[<xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref12" ref-type="bibr">12</xref>] Several studies show a beneficial effect of antioxidants in RA.[<xref rid="ref82" ref-type="bibr">82</xref><xref rid="ref83" ref-type="bibr">83</xref>] In a case&#x02013;control study by our group on 59 RA patients and 60 healthy sex and age-matched controls it was shown that in patients with RA Plasma MDA level was significantly higher and plasma concentration of beta-carotene, Vitamin E and Gluthation Reductase activity were significantly lower than healthy controls (<italic>P</italic> &#x0003c; 0.001).[<xref rid="ref12" ref-type="bibr">12</xref>] CLAs may confer antioxidant effect. Arab <italic>et al</italic>. studied the effects of some fatty acids on the redox status and lipid peroxidation of human fibroblasts, but only arachidonic acid and CLA enhanced Glutathion content through &#x003b3;-Glutamylcysteine ligase induction. CLA was more potent than arachidonic acid in Glutathion synthesis induction.[<xref rid="ref84" ref-type="bibr">84</xref>]</p><p>Several studies suggest positive effects of antioxidants such as Vitamin E in RA.[<xref rid="ref83" ref-type="bibr">83</xref><xref rid="ref85" ref-type="bibr">85</xref>]</p><p>The cellular responses to Vitamin E are associated with transcriptional and posttranscriptional events. Activation of diacylglycerol kinase and protein phosphatase 2&#x003b1;, and the inhibition of PKC, COX, lipoxygenase, tyrosine kinase phosphorylation, and cytokine release by Vitamin E are all examples of posttranscriptional regulation.[<xref rid="ref86" ref-type="bibr">86</xref>]</p><p>Vitamin E supplementation also resulted in the suppression of pro-inflammatory cytokines such as IL-6 and chemokines such as IL-8 and monocytes chemotactic protein-1 (MCP-1). Vitamin E also modulates cyclooxygenase-2 activity and inhibits thromboxane formation.[<xref rid="ref87" ref-type="bibr">87</xref>] In this study, we used Vitamin E supplementation as an antioxidant, and in combination with CLAs.</p><p>The lymphocytes increased in group P (<italic>P</italic> &#x02264; 0.05) and decreased in group CE nonsignificantly.</p><p>To the best of our knowledge, the effect of Vitamin E on cytokines in RA patients has not been investigated up to now. Pallest study (1999) in elderly person shows that Vitamin E increases IL4 and IL2 nonsignificantly,[<xref rid="ref88" ref-type="bibr">88</xref>] but alber study) 2003 (on rats shows Vitamin E reduces IL4 and INF&#x003b3; in spleen and lymph nodes.[<xref rid="ref40" ref-type="bibr">40</xref>] In van Tits <italic>et al</italic>. study &#x003b1;-tocopherol supplementation decreased production of cytokines and superoxide by leukocytes <italic>ex vivo</italic> in both hypertriglyceridemic and normolipidemic persons.[<xref rid="ref89" ref-type="bibr">89</xref>] In Mol <italic>et al</italic>. study was shown that the supplementation of 600 IU/d for four weeks decreased plasma IL-1&#x003b1;, TNF-&#x003b1;, and IL-1 &#x003b2; in smokers but not in diabetic patients.[<xref rid="ref10" ref-type="bibr">10</xref>]</p><p>In our study, Vitamin E supplementation for three months reduced IL4 and IL1 &#x003b2; significantly. The suggested mechanism may be either directly change in T-cell surface receptors or indirectly effect on macrophages, reduction in PGE2 and H<sub>2</sub>O<sub>2</sub> (product of activated macrophages).[<xref rid="ref90" ref-type="bibr">90</xref><xref rid="ref91" ref-type="bibr">91</xref>] Some studies show the effectiveness of Vitamin E on reducing the pain[<xref rid="ref29" ref-type="bibr">29</xref><xref rid="ref85" ref-type="bibr">85</xref><xref rid="ref86" ref-type="bibr">86</xref>] inflammation and other clinical outcomes that may verify our data.</p></sec><sec sec-type="conclusions" id="sec1-5"><title>CONCLUSIONS</title><p>In our study, 3-month co-supplementation with CLA and Vitamin E resulted in a significant reduction of WBC count, MMP-3, and TNF-&#x003b1; in patients with active RA. It seems that CLAs may decrease inflammation in patients with RA. Co-supplementation with Vitamin E could be helpful in increasing the antiinflammatory effects of CLAs on active RA, but further investigations are needed to determine the exact effects of CLAs on inflammation and Immunity in humans.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>This study was funded through a research grant from the Research Deputy of the Tehran University of Medical Sciences (with Proposal No., 2804). We are thankful for the cooperation of both Lipid Nutrition Company (Netherlands) for providing CLA capsules as Clarinol G-80 and Zahravi Company (Iran) for providing Vitamin E pearls for this research. We are thankful from Nafeese Aryaeian for editing the article.</p></ack><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Firestein</surname><given-names>GS</given-names></name></person-group><article-title>Etiology and pathogenesis of rheumatoid arthritis</article-title><source>Kelley's Textbook of Rheumatology</source><year>2008</year><volume>2</volume><edition>8th ed</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Saunders</publisher-name><fpage>1035</fpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Clair</surname><given-names>E</given-names></name><name><surname>Pisetsky</surname><given-names>W</given-names></name><name><surname>Haynes</surname><given-names>F</given-names></name></person-group><article-title>Rheumatoid Arthritis</article-title><year>2004</year><edition>2nd ed</edition><publisher-loc>USA</publisher-loc><publisher-name>Lippincott and Wilkins Inc</publisher-name></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heli&#x000f6;vaara</surname><given-names>M</given-names></name><name><surname>Knekt</surname><given-names>P</given-names></name><name><surname>Aho</surname><given-names>K</given-names></name><name><surname>Aaran</surname><given-names>RK</given-names></name><name><surname>Alfthan</surname><given-names>G</given-names></name><name><surname>Aromaa</surname><given-names>A</given-names></name></person-group><article-title>Serum antioxidants and risk of rheumatoid arthritis</article-title><source>Ann Rheum Dis</source><year>1994</year><volume>53</volume><fpage>51</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">8311556</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadjigogos</surname><given-names>K</given-names></name></person-group><article-title>The role of free radicals in the pathogenesis of rheumatoid arthritis</article-title><source>Panminerva Med</source><year>2003</year><volume>45</volume><fpage>7</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">12682616</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalpakcioglu</surname><given-names>B</given-names></name><name><surname>Senel</surname><given-names>K</given-names></name></person-group><article-title>The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis</article-title><source>Clin Rheumatol</source><year>2008</year><volume>27</volume><fpage>141</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17912575</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afonso</surname><given-names>V</given-names></name><name><surname>Champy</surname><given-names>R</given-names></name><name><surname>Mitrovic</surname><given-names>D</given-names></name><name><surname>Collin</surname><given-names>P</given-names></name><name><surname>Lomri</surname><given-names>A</given-names></name></person-group><article-title>Reactive oxygen species and superoxide dismutases: Role in joint diseases</article-title><source>Joint Bone Spine</source><year>2007</year><volume>74</volume><fpage>324</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17590367</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirshafiey</surname><given-names>A</given-names></name><name><surname>Mohsenzadegan</surname><given-names>M</given-names></name></person-group><article-title>The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis</article-title><source>Iran J Allergy Asthma Immunol</source><year>2008</year><volume>7</volume><fpage>195</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">19052348</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hitchon</surname><given-names>CA</given-names></name><name><surname>El-Gabalawy</surname><given-names>HS</given-names></name></person-group><article-title>Oxidation in rheumatoid arthritis</article-title><source>Arthritis Res Ther</source><year>2004</year><volume>6</volume><fpage>265</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">15535839</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauerov&#x000e1;</surname><given-names>K</given-names></name><name><surname>Bezek</surname><given-names>A</given-names></name></person-group><article-title>Role of reactive oxygen and nitrogen species in etiopathogenesis of rheumatoid arthritis</article-title><source>Gen Physiol Biophys</source><year>1999</year><volume>18</volume><issue>Spec No</issue><fpage>15</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">10703714</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mol</surname><given-names>MJ</given-names></name><name><surname>de Rijke</surname><given-names>YB</given-names></name><name><surname>Demacker</surname><given-names>PN</given-names></name><name><surname>Stalenhoef</surname><given-names>AF</given-names></name></person-group><article-title>Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: Effects of vitamin E treatment</article-title><source>Atherosclerosis</source><year>1997</year><volume>129</volume><fpage>169</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">9105558</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamanli</surname><given-names>A</given-names></name><name><surname>Naziroglu</surname><given-names>M</given-names></name><name><surname>Aydilek</surname><given-names>N</given-names></name><name><surname>Hacievliyagil</surname><given-names>C</given-names></name></person-group><article-title>Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis</article-title><source>Cell Biochem Funct</source><year>2004</year><volume>22</volume><fpage>53</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">14695655</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aryaeian</surname><given-names>N</given-names></name><name><surname>Djalali</surname><given-names>M</given-names></name><name><surname>Shahram</surname><given-names>F</given-names></name><name><surname>Jazayeri</surname><given-names>Sh</given-names></name><name><surname>Chamari</surname><given-names>M</given-names></name><name><surname>Nazari</surname><given-names>S</given-names></name></person-group><article-title>Beta-Carotene, Vitamin E, MDA, Glutathione Reductase and Arylesterase Activity Levels in Patients with Active Rheumatoid Arthritis</article-title><source>Iran J Public Health</source><year>2011</year><volume>40</volume><fpage>102</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">23113079</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knekt</surname><given-names>P</given-names></name><name><surname>Heli&#x000f6;vaara</surname><given-names>M</given-names></name><name><surname>Aho</surname><given-names>K</given-names></name><name><surname>Alfthan</surname><given-names>G</given-names></name><name><surname>Marniemi</surname><given-names>J</given-names></name><name><surname>Aromaa</surname><given-names>A</given-names></name></person-group><article-title>Serum selenium, serum alpha-tocopherol, and the risk of rheumatoid arthritis</article-title><source>Epidemiology</source><year>2000</year><volume>11</volume><fpage>402</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">10874546</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>O</given-names></name><name><surname>Cashman</surname><given-names>KD</given-names></name></person-group><article-title>The effect of conjugated linoleic acid on calcium absorption and bone metabolism and composition in adult ovariectomised rats</article-title><source>Prostaglandins Leukot Essent Fatty Acids</source><year>2004</year><volume>71</volume><fpage>295</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">15380816</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>O</given-names></name><name><surname>Cusack</surname><given-names>S</given-names></name><name><surname>Jewell</surname><given-names>C</given-names></name><name><surname>Cashman</surname><given-names>KD</given-names></name></person-group><article-title>The effect of polyunsaturated fatty acids, including conjugated linoleic acid, on calcium absorption and bone metabolism and composition in young growing rats</article-title><source>Br J Nutr</source><year>2003</year><volume>90</volume><fpage>743</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">13129442</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ip</surname><given-names>C</given-names></name><name><surname>Dong</surname><given-names>Y</given-names></name><name><surname>Ip</surname><given-names>MM</given-names></name><name><surname>Banni</surname><given-names>S</given-names></name><name><surname>Carta</surname><given-names>G</given-names></name><name><surname>Angioni</surname><given-names>E</given-names></name><etal/></person-group><article-title>Conjugated linoleic acid isomers and mammary cancer prevention</article-title><source>Nutr Cancer</source><year>2002</year><volume>43</volume><fpage>52</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12467135</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valeille</surname><given-names>K</given-names></name><name><surname>Gripois</surname><given-names>D</given-names></name><name><surname>Blouquit</surname><given-names>MF</given-names></name><name><surname>Souidi</surname><given-names>M</given-names></name><name><surname>Riottot</surname><given-names>M</given-names></name><name><surname>Bouthegourd</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Lipid atherogenic risk markers can be more favourably influenced by the cis-9, trans-11-octadecadienoate isomer than a conjugated linoleic acid mixture or fish oil in hamsters</article-title><source>Br J Nutr</source><year>2004</year><volume>91</volume><fpage>191</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">14756904</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valeille</surname><given-names>K</given-names></name><name><surname>F&#x000e9;r&#x000e9;zou</surname><given-names>J</given-names></name><name><surname>Amsler</surname><given-names>G</given-names></name><name><surname>Quignard-Boulang&#x000e9;</surname><given-names>A</given-names></name><name><surname>Parquet</surname><given-names>M</given-names></name><name><surname>Gripois</surname><given-names>D</given-names></name><etal/></person-group><article-title>A cis-9, trans-11-conjugated linoleic acid-rich oil reduces the outcome of atherogenic process in hyperlipidemic hamster</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2005</year><volume>289</volume><fpage>H652</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15778275</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houseknecht</surname><given-names>KL</given-names></name><name><surname>Vanden</surname><given-names>Heuvel JP</given-names></name><name><surname>Moya-Camarena</surname><given-names>SY</given-names></name><name><surname>Portocarrero</surname><given-names>CP</given-names></name><name><surname>Peck</surname><given-names>LW</given-names></name><name><surname>Nickel</surname><given-names>KP</given-names></name><etal/></person-group><article-title>Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat</article-title><source>Biochem Biophys Res Commun</source><year>1998</year><volume>244</volume><fpage>678</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">9535724</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banu</surname><given-names>J</given-names></name><name><surname>Bhattacharya</surname><given-names>A</given-names></name><name><surname>Rahman</surname><given-names>M</given-names></name><name><surname>O&#x02019;Shea</surname><given-names>M</given-names></name><name><surname>Fernandes</surname><given-names>G</given-names></name></person-group><article-title>Effects of conjugated linoleic acid and exercise on bone mass in young male Balb/C mice</article-title><source>Lipids Health Dis</source><year>2006</year><volume>5</volume><fpage>7</fpage><pub-id pub-id-type="pmid">16556311</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kung</surname><given-names>FC</given-names></name><name><surname>Yang</surname><given-names>MC</given-names></name></person-group><article-title>The effect of covalently bonded conjugated linoleic acid on the reduction of oxidative stress and blood coagulation for polysulfone hemodialyzer membrane</article-title><source>Int J Biol Macromol</source><year>2006</year><volume>38</volume><fpage>157</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">16677703</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kung</surname><given-names>FC</given-names></name><name><surname>Chang</surname><given-names>JJ</given-names></name><name><surname>Yang</surname><given-names>MC</given-names></name></person-group><article-title>The reduction of oxidative stress, anticoagulation of platelets, and inhibition of lipopolysaccharide by conjugated linoleic acid bonded on a polysulfone membrane</article-title><source>Polym Adv Technol</source><year>2007</year><volume>18</volume><fpage>286</fpage><lpage>91</lpage></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossary</surname><given-names>A</given-names></name><name><surname>Arab</surname><given-names>K</given-names></name><name><surname>Steghens</surname><given-names>JP</given-names></name></person-group><article-title>Polyunsaturated fatty acids modulate NOX4 anion superoxide production in human fibroblasts</article-title><source>Biochem J</source><year>2007</year><volume>406</volume><fpage>77</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">17472580</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergamo</surname><given-names>P</given-names></name><name><surname>Luongo</surname><given-names>D</given-names></name><name><surname>Maurano</surname><given-names>F</given-names></name><name><surname>Mazzarella</surname><given-names>G</given-names></name><name><surname>Stefanile</surname><given-names>R</given-names></name><name><surname>Rossi</surname><given-names>M</given-names></name></person-group><article-title>Conjugated linoleic acid enhances glutathione synthesis and attenuates pathological signs in MRL/MpJ-Fas (lpr) mice</article-title><source>J Lipid Res</source><year>2006</year><volume>47</volume><fpage>2382</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">16877747</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>ND</given-names></name><name><surname>Liu</surname><given-names>XW</given-names></name><name><surname>Kim</surname><given-names>MR</given-names></name><name><surname>Jeong</surname><given-names>TS</given-names></name><name><surname>Sok</surname><given-names>DE</given-names></name></person-group><article-title>Protective action of CLA against oxidative inactivation of paraoxonase 1, an antioxidant enzyme</article-title><source>Lipids</source><year>2003</year><volume>38</volume><fpage>615</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">12934671</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>L</given-names></name></person-group><article-title>Free radical scavenging properties of conjugated linoleic acids</article-title><source>J Agric Food Chem</source><year>2001</year><volume>49</volume><fpage>3452</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11453790</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HK</given-names></name><name><surname>Kim</surname><given-names>SR</given-names></name><name><surname>Ahn</surname><given-names>JY</given-names></name><name><surname>Cho</surname><given-names>IJ</given-names></name><name><surname>Yoon</surname><given-names>CS</given-names></name><name><surname>Ha</surname><given-names>TY</given-names></name></person-group><article-title>Dietary conjugated linoleic acid reduces lipid peroxidation by increasing oxidative stability in rats</article-title><source>J Nutr Sci Vitaminol (Tokyo)</source><year>2005</year><volume>51</volume><fpage>8</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">15915662</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aryaeian</surname><given-names>N</given-names></name><name><surname>Shahram</surname><given-names>F</given-names></name><name><surname>Djalali</surname><given-names>M</given-names></name><name><surname>Eshragian</surname><given-names>MR</given-names></name><name><surname>Djazayeri</surname><given-names>A</given-names></name><name><surname>Sarrafnejad</surname><given-names>A</given-names></name><etal/></person-group><article-title>Effect of conjugated linoleic acids, vitamin E and their combination on the clinical outcome of Iranian adults with active rheumatoid arthritis</article-title><source>Int J Rheum Dis</source><year>2009</year><volume>12</volume><fpage>20</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">20374312</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aryaeian</surname><given-names>N</given-names></name><name><surname>Shahram</surname><given-names>F</given-names></name><name><surname>Djalali</surname><given-names>M</given-names></name><name><surname>Djazayeri</surname><given-names>A</given-names></name><name><surname>Eshragian</surname><given-names>MR</given-names></name><name><surname>Naderi</surname><given-names>N</given-names></name><etal/></person-group><article-title>The effect of conjugated linoleic acids, vitamin e and their combination on lipid peroxidation in active rheumatoid arthritis</article-title><source>Iran J Public Health</source><year>2009</year><volume>38</volume><fpage>79</fpage><lpage>89</lpage></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aryaeian</surname><given-names>N</given-names></name><name><surname>Shahram</surname><given-names>F</given-names></name><name><surname>Djalali</surname><given-names>M</given-names></name><name><surname>Djazayeri</surname><given-names>A</given-names></name><name><surname>Eshragian</surname><given-names>MR</given-names></name><name><surname>Sarrafnejad</surname><given-names>A</given-names></name><etal/></person-group><article-title>Effect of conjugated linoleic acid, vitamin E and their combination on lipid profiles and blood pressure of Iranian adultswith active rheumatoid arthritis</article-title><source>Vasc Health Risk Manag</source><year>2008</year><volume>4</volume><fpage>1423</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">19337555</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Barnes</surname><given-names>D</given-names></name><name><surname>Butz</surname><given-names>D</given-names></name><name><surname>Bjorling</surname><given-names>D</given-names></name><name><surname>Cook</surname><given-names>ME</given-names></name></person-group><article-title>10th, 12c-conjugated linoleic acid inhibits lipopolysaccharide-induced cyclooxygenase expression <italic>in vitro</italic> and <italic>in vivo</italic></article-title><source>J Lipid Res</source><year>2005</year><volume>46</volume><fpage>2134</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">16061956</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clare</surname><given-names>MR</given-names></name><name><surname>Draper</surname><given-names>E</given-names></name><name><surname>Keogh</surname><given-names>B</given-names></name><name><surname>Rahman</surname><given-names>A</given-names></name><name><surname>Moloney</surname><given-names>AP</given-names></name><name><surname>Kingston</surname><given-names>HG</given-names></name><etal/></person-group><article-title>A Conjugated linoleic acid-enriched beef diet attenuates lipopolysaccharide-induced inflammationin mice through ppar&#x003b3; mediated suppregion of toll-likereceptor 4</article-title><source>J Nutr</source><year>2009</year><volume>139</volume><fpage>2351</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">19846417</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Changhua</surname><given-names>L</given-names></name><name><surname>Jindong</surname><given-names>Y</given-names></name><name><surname>Defa</surname><given-names>L</given-names></name><name><surname>Lidan</surname><given-names>Z</given-names></name><name><surname>Shiyan</surname><given-names>Q</given-names></name><name><surname>Jianjun</surname><given-names>X</given-names></name></person-group><article-title>Conjugated linoleic acid attenuates the production and gene expression of proinflammatory cytokines in weaned pigs challenged with lipopolysaccharide</article-title><source>J Nutr</source><year>2005</year><volume>135</volume><fpage>239</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">15671220</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Shea</surname><given-names>M</given-names></name><name><surname>Bassaganya-Riera</surname><given-names>J</given-names></name><name><surname>Mohede</surname><given-names>IC</given-names></name></person-group><article-title>Immunomodulatory properties of conjugated linoleic acid</article-title><source>Am J Clin Nutr</source><year>2004</year><volume>79</volume><fpage>1199S</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">15159257</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugano</surname><given-names>M</given-names></name><name><surname>Tsujita</surname><given-names>A</given-names></name><name><surname>Yamasaki</surname><given-names>M</given-names></name><name><surname>Noguchi</surname><given-names>M</given-names></name><name><surname>Yamada</surname><given-names>K</given-names></name></person-group><article-title>Conjugated linoleic acid modulates tissue levels of chemical mediators and immunoglobulins in rats</article-title><source>Lipids</source><year>1998</year><volume>33</volume><fpage>521</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9625600</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Correll</surname><given-names>PH</given-names></name><name><surname>Vanden</surname><given-names>Heuvel JP</given-names></name></person-group><article-title>Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: Evidence for a PPAR gamma-dependent mechanism</article-title><source>Biochim Biophys Acta</source><year>2002</year><volume>1581</volume><fpage>89</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">12020636</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>ME</given-names></name><name><surname>Butz</surname><given-names>DE</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Pariza</surname><given-names>MW</given-names></name><name><surname>Whigham</surname><given-names>LD</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name></person-group><article-title>Conjugated linoleic acid enhances immune responses but protects against the collateral dammage of immune events</article-title><source>Advances in Conjugated Linoleic Acid</source><year>2003</year><publisher-loc>USA</publisher-loc><publisher-name>AOCS Press</publisher-name><fpage>283</fpage><lpage>91</lpage></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fritsche</surname><given-names>K</given-names></name></person-group><article-title>Fatty acids as modulators of the immune response</article-title><source>Annu Rev Nutr</source><year>2006</year><volume>26</volume><fpage>45</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">16848700</pub-id></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>ME</given-names></name></person-group><article-title>Conjugated linoleic acid's role in immunity and immune related disorders. Perspectives on conjugated linoleic acid research: Current status and future directions</article-title><year>2002</year><publisher-loc>19, NIH, Bethesda, Maryland</publisher-loc><publisher-name>Lister Hill Auditorium</publisher-name></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albers</surname><given-names>R</given-names></name><name><surname>van der Wielen</surname><given-names>RP</given-names></name><name><surname>Brink</surname><given-names>EJ</given-names></name><name><surname>Hendriks</surname><given-names>HF</given-names></name><name><surname>Dorovska-Taran</surname><given-names>VN</given-names></name><name><surname>Mohede</surname><given-names>IC</given-names></name></person-group><article-title>Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy men</article-title><source>Eur J Clin Nutr</source><year>2003</year><volume>57</volume><fpage>595</fpage><lpage>603</lpage><pub-id pub-id-type="pmid">12700622</pub-id></element-citation></ref><ref id="ref41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelley</surname><given-names>DS</given-names></name><name><surname>Simon</surname><given-names>VA</given-names></name><name><surname>Taylor</surname><given-names>PC</given-names></name><name><surname>Rudolph</surname><given-names>IL</given-names></name><name><surname>Benito</surname><given-names>P</given-names></name><name><surname>Nelson</surname><given-names>GJ</given-names></name><etal/></person-group><article-title>Dietary supplementation with conjugated linoleic acid increased its concentration in human peripheral blood mononuclear cells, but did not alter their function</article-title><source>Lipids</source><year>2001</year><volume>36</volume><fpage>669</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">11521964</pub-id></element-citation></ref><ref id="ref42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calder</surname><given-names>PC</given-names></name><name><surname>Grimble</surname><given-names>RF</given-names></name></person-group><article-title>Polyunsaturated fatty acids, inflammation and immunity</article-title><source>Eur J Clin Nutr</source><year>2002</year><volume>56</volume><issue>Suppl 3</issue><fpage>S14</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12142955</pub-id></element-citation></ref><ref id="ref43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>HJ</given-names></name><name><surname>Grant</surname><given-names>I</given-names></name><name><surname>Rotondo</surname><given-names>D</given-names></name><name><surname>Mohede</surname><given-names>I</given-names></name><name><surname>Sattar</surname><given-names>N</given-names></name><name><surname>Heys</surname><given-names>SD</given-names></name><etal/></person-group><article-title>Effect of CLA supplementation on immune function in young healthy volunteers</article-title><source>Eur J Clin Nutr</source><year>2005</year><volume>59</volume><fpage>508</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">15674307</pub-id></element-citation></ref><ref id="ref44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nugent</surname><given-names>AP</given-names></name><name><surname>Roche</surname><given-names>HM</given-names></name><name><surname>Noone</surname><given-names>EJ</given-names></name><name><surname>Long</surname><given-names>A</given-names></name><name><surname>Kelleher</surname><given-names>DK</given-names></name><name><surname>Gibney</surname><given-names>MJ</given-names></name></person-group><article-title>The effects of conjugated linoleic acid supplementation on immune function in healthy volunteers</article-title><source>Eur J Clin Nutr</source><year>2005</year><volume>59</volume><fpage>742</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">15827560</pub-id></element-citation></ref><ref id="ref45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smedman</surname><given-names>A</given-names></name><name><surname>Basu</surname><given-names>S</given-names></name><name><surname>Jovinge</surname><given-names>S</given-names></name><name><surname>Fredrikson</surname><given-names>GN</given-names></name><name><surname>Vessby</surname><given-names>B</given-names></name></person-group><article-title>Conjugated linoleic acid increased C-reactive protein in human subjects</article-title><source>Br J Nutr</source><year>2005</year><volume>94</volume><fpage>791</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">16277783</pub-id></element-citation></ref><ref id="ref46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ris&#x000e9;rus</surname><given-names>U</given-names></name><name><surname>Basu</surname><given-names>S</given-names></name><name><surname>Jovinge</surname><given-names>S</given-names></name><name><surname>Fredrikson</surname><given-names>GN</given-names></name><name><surname>Arnl&#x000f6;v</surname><given-names>J</given-names></name><name><surname>Vessby</surname><given-names>B</given-names></name></person-group><article-title>Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: A potential link to fatty acid-induced insulin resistance</article-title><source>Circulation</source><year>2002</year><volume>106</volume><fpage>1925</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12370214</pub-id></element-citation></ref><ref id="ref47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moloney</surname><given-names>F</given-names></name><name><surname>Yeow</surname><given-names>TP</given-names></name><name><surname>Mullen</surname><given-names>A</given-names></name><name><surname>Nolan</surname><given-names>JJ</given-names></name><name><surname>Roche</surname><given-names>HM</given-names></name></person-group><article-title>Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus</article-title><source>Am J Clin Nutr</source><year>2004</year><volume>80</volume><fpage>887</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">15447895</pub-id></element-citation></ref><ref id="ref48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raff</surname><given-names>M</given-names></name><name><surname>Tholstrup</surname><given-names>T</given-names></name><name><surname>Basu</surname><given-names>S</given-names></name><name><surname>Nonboe</surname><given-names>P</given-names></name><name><surname>S&#x000f8;rensen</surname><given-names>MT</given-names></name><name><surname>Straarup</surname><given-names>EM</given-names></name></person-group><article-title>A diet rich in conjugated linoleic acid and butter increases lipid peroxidation but does not affect atherosclerotic, inflammatory, or diabetic risk markers in healthy young men</article-title><source>J Nutr</source><year>2008</year><volume>138</volume><fpage>509</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">18287358</pub-id></element-citation></ref><ref id="ref49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnett</surname><given-names>FC</given-names></name><name><surname>Edworthy</surname><given-names>SM</given-names></name><name><surname>Bloch</surname><given-names>DA</given-names></name><name><surname>McShane</surname><given-names>DJ</given-names></name><name><surname>Fries</surname><given-names>JF</given-names></name><name><surname>Cooper</surname><given-names>NS</given-names></name><etal/></person-group><article-title>The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis</article-title><source>Arthritis Rheum</source><year>1988</year><volume>31</volume><fpage>315</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">3358796</pub-id></element-citation></ref><ref id="ref50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuesta</surname><given-names>Sanz D</given-names></name><name><surname>Castro</surname><given-names>Santa-Cruz M</given-names></name></person-group><article-title>Simultaneous measurement of retinol and alpha-tocopherol in human serum by high-performance liquid chromatography with ultraviolet detection</article-title><source>J Chromatogr</source><year>1986</year><volume>380</volume><fpage>140</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">3745376</pub-id></element-citation></ref><ref id="ref51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Brien</surname><given-names>SM</given-names></name><name><surname>Scully</surname><given-names>P</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name></person-group><article-title>Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia</article-title><source>Psychiatry Res</source><year>2008</year><volume>160</volume><fpage>256</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">18722671</pub-id></element-citation></ref><ref id="ref52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furuzawa-Carballeda</surname><given-names>J</given-names></name><name><surname>Macip-Rodr&#x000ed;guez</surname><given-names>PM</given-names></name><name><surname>Cabral</surname><given-names>AR</given-names></name></person-group><article-title>Osteoarthritis and rheumatoid arthritis pannus have similar qualitative metabolic characteristics and pro-inflammatory cytokine response</article-title><source>Clin Exp Rheumatol</source><year>2008</year><volume>26</volume><fpage>554</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">18799084</pub-id></element-citation></ref><ref id="ref53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullen</surname><given-names>A</given-names></name><name><surname>Moloney</surname><given-names>F</given-names></name><name><surname>Nugent</surname><given-names>AP</given-names></name><name><surname>Doyle</surname><given-names>L</given-names></name><name><surname>Cashman</surname><given-names>KD</given-names></name><name><surname>Roche</surname><given-names>HM</given-names></name></person-group><article-title>Conjugated linoleic acid supplementation reduces peripheral blood mononuclear cell interleukin-2 production in healthy middle-aged males</article-title><source>J Nutr Biochem</source><year>2007</year><volume>18</volume><fpage>658</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">17368881</pub-id></element-citation></ref><ref id="ref54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukuda</surname><given-names>K</given-names></name><name><surname>Fujitsu</surname><given-names>Y</given-names></name><name><surname>Kumagai</surname><given-names>N</given-names></name><name><surname>Nishida</surname><given-names>T</given-names></name></person-group><article-title>Inhibition of matrix metalloproteinase-3 synthesis in human conjunctival fibroblasts by interleukin-4 or interleukin-13</article-title><source>Invest Ophthalmol Vis Sci</source><year>2006</year><volume>47</volume><fpage>2857</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">16799025</pub-id></element-citation></ref><ref id="ref55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>C</given-names></name><name><surname>Nogueira</surname><given-names>L</given-names></name><name><surname>Sebbag</surname><given-names>M</given-names></name><name><surname>Chapuy-Regaud</surname><given-names>S</given-names></name><name><surname>Arnaud</surname><given-names>M</given-names></name><name><surname>Letourneur</surname><given-names>O</given-names></name><etal/></person-group><article-title>Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: A highly effective test for the diagnosis of rheumatoid arthritis</article-title><source>Arthritis Rheum</source><year>2002</year><volume>46</volume><fpage>2051</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12209508</pub-id></element-citation></ref><ref id="ref56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacRedmond</surname><given-names>R</given-names></name><name><surname>Singhera</surname><given-names>G</given-names></name><name><surname>Attridge</surname><given-names>S</given-names></name><name><surname>Bahzad</surname><given-names>M</given-names></name><name><surname>Fava</surname><given-names>C</given-names></name><name><surname>Lai</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Conjugated linoleic acid improves airway hyper-reactivity in overweight mild asthmatics</article-title><source>Clin Exp Allergy</source><year>2010</year><volume>40</volume><fpage>1071</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">20642580</pub-id></element-citation></ref><ref id="ref57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Pariza</surname><given-names>MW</given-names></name><name><surname>Cook</surname><given-names>ME</given-names></name></person-group><article-title>Dietary conjugated linoleic acid protects against end stage disease of systemic lupus erythematosus in the NZB/W F1 mouse</article-title><source>Immunopharmacol Immunotoxicol</source><year>2000</year><volume>22</volume><fpage>433</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">10946824</pub-id></element-citation></ref><ref id="ref58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>HS</given-names></name><name><surname>Ryu</surname><given-names>JH</given-names></name><name><surname>Ha</surname><given-names>YL</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name></person-group><article-title>Dietary conjugated linoleic acid (CLA) induces apoptosis of colonic mucosa in 1,2-dimethylhydrazine-treated rats: A possible mechanism of the anticarcinogenic effect by CLA</article-title><source>Br J Nutr</source><year>2001</year><volume>86</volume><fpage>549</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">11737953</pub-id></element-citation></ref><ref id="ref59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Cook</surname><given-names>ME</given-names></name></person-group><article-title>Dietary conjugated linoleic acid decreased cachexia, macrophage tumor necrosis factor-alpha production, and modifies splenocyte cytokines production</article-title><source>Exp Biol Med (Maywood)</source><year>2003</year><volume>228</volume><fpage>51</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12524473</pub-id></element-citation></ref><ref id="ref60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hontecillas</surname><given-names>R</given-names></name><name><surname>Wannemeulher</surname><given-names>MJ</given-names></name><name><surname>Zimmerman</surname><given-names>DR</given-names></name><name><surname>Hutto</surname><given-names>DL</given-names></name><name><surname>Wilson</surname><given-names>JH</given-names></name><name><surname>Ahn</surname><given-names>DU</given-names></name><etal/></person-group><article-title>Nutritional regulation of porcine bacterial-induced colitis by conjugated linoleic acid</article-title><source>J Nutr</source><year>2002</year><volume>132</volume><fpage>2019</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">12097686</pub-id></element-citation></ref><ref id="ref61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Cook</surname><given-names>ME</given-names></name></person-group><article-title>Dietary CLA decreased weight loss and extended survival following the onset of kidney failure in NZB/W F1 mice</article-title><source>Lipids</source><year>2003</year><volume>38</volume><fpage>21</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">12669815</pub-id></element-citation></ref><ref id="ref62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turek</surname><given-names>JJ</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Schoenlein</surname><given-names>IA</given-names></name><name><surname>Allen</surname><given-names>KG</given-names></name><name><surname>Watkins</surname><given-names>BA</given-names></name></person-group><article-title>Modulation of macrophage cytokine production by conjugated linoleic acids</article-title><source>J Nutr Biochem</source><year>1998</year><volume>9</volume><fpage>258</fpage><lpage>66</lpage></element-citation></ref><ref id="ref63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hur</surname><given-names>SJ</given-names></name><name><surname>Park</surname><given-names>Y</given-names></name></person-group><article-title>Effect of conjugated linoleic acid on bone formation and rheumatoid arthritis</article-title><source>Eur J Pharmacol</source><year>2007</year><volume>568</volume><fpage>16</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">17573069</pub-id></element-citation></ref><ref id="ref64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Degner</surname><given-names>SC</given-names></name><name><surname>Kemp</surname><given-names>MQ</given-names></name><name><surname>Bowden</surname><given-names>GT</given-names></name><name><surname>Romagnolo</surname><given-names>DF</given-names></name></person-group><article-title>Conjugated linoleic acid attenuates cyclooxygenase-2 transcriptional activity via an anti-AP-1 mechanism in MCF-7 breast cancer cells</article-title><source>J Nutr</source><year>2006</year><volume>136</volume><fpage>421</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16424122</pub-id></element-citation></ref><ref id="ref65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huebner</surname><given-names>SM</given-names></name><name><surname>Campbell</surname><given-names>JP</given-names></name><name><surname>Butz</surname><given-names>DE</given-names></name><name><surname>Fulmer</surname><given-names>TG</given-names></name><name><surname>Gendron-Fitzpatrick</surname><given-names>A</given-names></name><name><surname>Cook</surname><given-names>ME</given-names></name></person-group><article-title>Individual isomers of conjugated linoleic acid reduce inflammation associated with established collagen-induced arthritis in DBA/1 mice</article-title><source>J Nutr</source><year>2010</year><volume>140</volume><fpage>1454</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">20573944</pub-id></element-citation></ref><ref id="ref66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butz</surname><given-names>DE</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Huebner</surname><given-names>SM</given-names></name><name><surname>Cook</surname><given-names>ME</given-names></name></person-group><article-title>A mechanistic approach to understanding conjugated linoleic acid's role in inflammation using murine models of rheumatoid arthritis</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><year>2007</year><volume>293</volume><fpage>R669</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">17553852</pub-id></element-citation></ref><ref id="ref67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shovman</surname><given-names>O</given-names></name><name><surname>Gilburd</surname><given-names>B</given-names></name><name><surname>Zandman-Goddard</surname><given-names>G</given-names></name><name><surname>Sherer</surname><given-names>Y</given-names></name><name><surname>Orbach</surname><given-names>H</given-names></name><name><surname>Gerli</surname><given-names>R</given-names></name><etal/></person-group><article-title>The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis</article-title><source>Clin Dev Immunol</source><year>2005</year><volume>12</volume><fpage>197</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">16295525</pub-id></element-citation></ref><ref id="ref68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miriovsky</surname><given-names>BJ</given-names></name><name><surname>Michaud</surname><given-names>K</given-names></name><name><surname>Thiele</surname><given-names>GM</given-names></name><name><surname>O&#x02019;Dell</surname><given-names>JR</given-names></name><name><surname>Cannon</surname><given-names>GW</given-names></name><name><surname>Kerr</surname><given-names>G</given-names></name><etal/></person-group><article-title>Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis</article-title><source>Ann Rheum Dis</source><year>2010</year><volume>69</volume><fpage>1292</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">20439294</pub-id></element-citation></ref><ref id="ref69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Firestein</surname><given-names>GS</given-names></name></person-group><article-title>Evolving concepts of rheumatoid arthritis</article-title><source>Nature</source><year>2003</year><volume>423</volume><fpage>356</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">12748655</pub-id></element-citation></ref><ref id="ref70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akahoshi</surname><given-names>A</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name><name><surname>Murao</surname><given-names>K</given-names></name><name><surname>Miyazaki</surname><given-names>T</given-names></name><name><surname>Yamasaki</surname><given-names>M</given-names></name><name><surname>Nonaka</surname><given-names>M</given-names></name><etal/></person-group><article-title>Conjugated linoleic acid reduces body fats and cytokine levels of mice</article-title><source>Biosci Biotechnol Biochem</source><year>2002</year><volume>66</volume><fpage>916</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">12036077</pub-id></element-citation></ref><ref id="ref71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Storkson</surname><given-names>JM</given-names></name><name><surname>Albrigh</surname><given-names>KJ</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Cook</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Effects of conjugated linoleic acid (CLA) isomers on serum tumor necrosis factor-&#x003b1; concentration in mice</article-title><source>J. Food Biochem</source><year>2007</year><volume>31</volume><fpage>252</fpage><lpage>65</lpage></element-citation></ref><ref id="ref72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>DI</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Jung</surname><given-names>EM</given-names></name><name><surname>Kang</surname><given-names>JH</given-names></name><name><surname>Jeung</surname><given-names>EB</given-names></name><etal/></person-group><article-title>Trans-10, cis-12-conjugated linoleic acid attenuates tumor necrosis factor-a production by lipopolysaccharide-stimulated porcine peripheral blood mononuclear cells through induction of interleukin-10</article-title><source>Cytokine</source><year>2011</year><volume>56</volume><fpage>224</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">21795062</pub-id></element-citation></ref><ref id="ref73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaudszus</surname><given-names>A</given-names></name><name><surname>Foerster</surname><given-names>M</given-names></name><name><surname>Kroegel</surname><given-names>C</given-names></name><name><surname>Wolf</surname><given-names>I</given-names></name><name><surname>Jahreis</surname><given-names>G</given-names></name></person-group><article-title>Cis-9, trans-11-CLA exerts anti-inflammatory effects in human bronchial epithelial cells and eosinophils: Comparison to trans-10, cis-12-CLA and to linoleic acid</article-title><source>Biochim Biophys Acta</source><year>2005</year><volume>1737</volume><fpage>111</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16303327</pub-id></element-citation></ref><ref id="ref74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Yin</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Lai</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>D</given-names></name></person-group><article-title>Conjugated linoleic acid can prevent tumor necrosis factor gene expression by inhibiting nuclear factor binding activity in peripheral blood mononuclear cells from weaned pigs challenged with lipopolysaccharide</article-title><source>Arch Anim Nutr</source><year>2005</year><volume>59</volume><fpage>429</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">16429828</pub-id></element-citation></ref><ref id="ref75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayek</surname><given-names>MG</given-names></name><name><surname>Han</surname><given-names>SN</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Watkins</surname><given-names>BA</given-names></name><name><surname>Meydani</surname><given-names>M</given-names></name><name><surname>Dorsey</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Dietary conjugated linoleic acid influences the immune response of young and old C57BL/6NCrlBR mice</article-title><source>J Nutr</source><year>1999</year><volume>129</volume><fpage>32</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9915872</pub-id></element-citation></ref><ref id="ref76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roche</surname><given-names>HM</given-names></name><name><surname>Noone</surname><given-names>E</given-names></name><name><surname>Sewter</surname><given-names>C</given-names></name><name><surname>Mc Bennett</surname><given-names>S</given-names></name><name><surname>Savage</surname><given-names>D</given-names></name><name><surname>Gibney</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Isomer-dependent metabolic effects of conjugated linoleic acid: Insights from molecular markers sterol regulatory element-binding protein-1c and LXRalpha</article-title><source>Diabetes</source><year>2002</year><volume>51</volume><fpage>2037</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">12086931</pub-id></element-citation></ref><ref id="ref77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parra</surname><given-names>P</given-names></name><name><surname>Serra</surname><given-names>F</given-names></name><name><surname>Palou</surname><given-names>A</given-names></name></person-group><article-title>Moderate doses of conjugated linoleic acid isomers mix contribute to lowering body fat content maintaining insulin sensitivity and a noninflammatory pattern in adipose tissue in mice</article-title><source>J Nutr Biochem</source><year>2010</year><volume>21</volume><fpage>107</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">19195867</pub-id></element-citation></ref><ref id="ref78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moya-Camarena</surname><given-names>SY</given-names></name><name><surname>Vanden</surname><given-names>Heuvel JP</given-names></name><name><surname>Blanchard</surname><given-names>SG</given-names></name><name><surname>Leesnitzer</surname><given-names>LA</given-names></name><name><surname>Belury</surname><given-names>MA</given-names></name></person-group><article-title>Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha</article-title><source>J Lipid Res</source><year>1999</year><volume>40</volume><fpage>1426</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">10428978</pub-id></element-citation></ref><ref id="ref79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>NP</given-names></name><name><surname>Misyak</surname><given-names>SA</given-names></name><name><surname>Schmelz</surname><given-names>EM</given-names></name><name><surname>Guri</surname><given-names>AJ</given-names></name><name><surname>Hontecillas</surname><given-names>R</given-names></name><name><surname>Bassaganya-Riera</surname><given-names>J</given-names></name></person-group><article-title>Conjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPARgamma</article-title><source>J Nutr</source><year>2010</year><volume>140</volume><fpage>515</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">20089779</pub-id></element-citation></ref><ref id="ref80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>WL</given-names></name><name><surname>Lii</surname><given-names>CK</given-names></name><name><surname>Chen</surname><given-names>HW</given-names></name><name><surname>Lin</surname><given-names>TH</given-names></name><name><surname>Liu</surname><given-names>KL</given-names></name></person-group><article-title>Contribution of conjugated linoleic acid to the suppression of inflammatory responses through the regulation of the NF-kappaB pathway</article-title><source>J Agric Food Chem</source><year>2004</year><volume>52</volume><fpage>71</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">14709015</pub-id></element-citation></ref><ref id="ref81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stachowska</surname><given-names>E</given-names></name><name><surname>Dolegowska</surname><given-names>B</given-names></name><name><surname>Dziedziejko</surname><given-names>V</given-names></name><name><surname>Rybicka</surname><given-names>M</given-names></name><name><surname>Kaczmarczyk</surname><given-names>M</given-names></name><name><surname>Bober</surname><given-names>J</given-names></name><etal/></person-group><article-title>Prostaglandin E2 (PGE2) and thromboxane A2 (TXA2) synthesis is regulated by conjugated linoleic acids (CLA) in human macrophages</article-title><source>J Physiol Pharmacol</source><year>2009</year><volume>60</volume><fpage>77</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">19439810</pub-id></element-citation></ref><ref id="ref82"><label>82</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wener</surname><given-names>MH</given-names></name></person-group><person-group person-group-type="editor"><name><surname>William</surname><given-names>ST</given-names></name><name><surname>Pisetsky</surname><given-names>DS</given-names></name><name><surname>Hayens</surname><given-names>BF</given-names></name></person-group><article-title>Auto antibodies and other laboratoty tests</article-title><source>Rheumatoid Arthritis</source><year>2004</year><publisher-loc>Philadelphia</publisher-loc><publisher-name>Lipincott Williams</publisher-name><fpage>64</fpage><lpage>79</lpage></element-citation></ref><ref id="ref83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comstock</surname><given-names>GW</given-names></name><name><surname>Burke</surname><given-names>AE</given-names></name><name><surname>Hoffman</surname><given-names>SC</given-names></name><name><surname>Helzlsouer</surname><given-names>KJ</given-names></name><name><surname>Bendich</surname><given-names>A</given-names></name><name><surname>Masi</surname><given-names>AT</given-names></name><etal/></person-group><article-title>Serum concentrations of alpha tocopherol, beta carotene, and retinol preceding the diagnosis of rheumatoid arthritis and systemic lupus erythematosus</article-title><source>Ann Rheum Dis</source><year>1997</year><volume>56</volume><fpage>323</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">9175934</pub-id></element-citation></ref><ref id="ref84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arab</surname><given-names>K</given-names></name><name><surname>Rossary</surname><given-names>A</given-names></name><name><surname>Soul&#x000e8;re</surname><given-names>L</given-names></name><name><surname>Steghens</surname><given-names>JP</given-names></name></person-group><article-title>Conjugated linoleic acid, unlike other unsaturated fatty acids, strongly induces glutathione synthesis without any lipoperoxidation</article-title><source>Br J Nutr</source><year>2006</year><volume>96</volume><fpage>811</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17092368</pub-id></element-citation></ref><ref id="ref85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edmonds</surname><given-names>SE</given-names></name><name><surname>Winyard</surname><given-names>PG</given-names></name><name><surname>Guo</surname><given-names>R</given-names></name><name><surname>Kidd</surname><given-names>B</given-names></name><name><surname>Merry</surname><given-names>P</given-names></name><name><surname>Langrish-Smith</surname><given-names>A</given-names></name><etal/></person-group><article-title>Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial</article-title><source>Ann Rheum Dis</source><year>1997</year><volume>56</volume><fpage>649</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">9462166</pub-id></element-citation></ref><ref id="ref86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>U</given-names></name><name><surname>Devaraj</surname><given-names>S</given-names></name><name><surname>Jialal</surname><given-names>I</given-names></name></person-group><article-title>Vitamin E, oxidative stress, and inflammation</article-title><source>Annu Rev Nutr</source><year>2005</year><volume>25</volume><fpage>151</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">16011463</pub-id></element-citation></ref><ref id="ref87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meydani</surname><given-names>SN</given-names></name></person-group><article-title>Vitamin E modulation of cardiovascular disease</article-title><source>Ann N Y Acad Sci</source><year>2004</year><volume>1031</volume><fpage>271</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15753153</pub-id></element-citation></ref><ref id="ref88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pallast</surname><given-names>EG</given-names></name><name><surname>Schouten</surname><given-names>EG</given-names></name><name><surname>de Waart</surname><given-names>FG</given-names></name><name><surname>Fonk</surname><given-names>HC</given-names></name><name><surname>Doekes</surname><given-names>G</given-names></name><name><surname>von Blomberg</surname><given-names>BM</given-names></name><etal/></person-group><article-title>Effect of 50- and 100-mg vitamin E supplements on cellular immune function in noninstitutionalized elderly persons</article-title><source>Am J Clin Nutr</source><year>1999</year><volume>69</volume><fpage>1273</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">10357750</pub-id></element-citation></ref><ref id="ref89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Tits</surname><given-names>LJ</given-names></name><name><surname>Demacker</surname><given-names>PN</given-names></name><name><surname>de Graaf</surname><given-names>J</given-names></name><name><surname>Hak-Lemmers</surname><given-names>HL</given-names></name><name><surname>Stalenhoef</surname><given-names>AF</given-names></name></person-group><article-title>alpha-tocopherol supplementation decreases production of superoxide and cytokines by leukocytes <italic>ex vivo</italic> in both normolipidemic and hypertriglyceridemic individuals</article-title><source>Am J Clin Nutr</source><year>2000</year><volume>71</volume><fpage>458</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">10648258</pub-id></element-citation></ref><ref id="ref90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beharka</surname><given-names>AA</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Han</surname><given-names>SN</given-names></name><name><surname>Meydani</surname><given-names>SN</given-names></name></person-group><article-title>Macrophage prostaglandin production contributes to the age-associated decrease in T cell function which is reversed by the dietary antioxidant vitamin E</article-title><source>Mech Ageing Dev</source><year>1997</year><volume>93</volume><fpage>59</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">9089571</pub-id></element-citation></ref><ref id="ref91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beharka</surname><given-names>AA</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Serafini</surname><given-names>M</given-names></name><name><surname>Meydani</surname><given-names>SN</given-names></name></person-group><article-title>Mechanism of vitamin E inhibition of cyclooxygenase activity in macrophages from old mice: Role of peroxynitrite</article-title><source>Free Radic Biol Med</source><year>2002</year><volume>32</volume><fpage>503</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">11958951</pub-id></element-citation></ref></ref-list></back></article>